JPRN-UMIN000001115已完成2 期
a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancer - PII of AMR/CBDCA for EDSCLC
agasaki Thoracic Oncology Group0 个研究点目标入组 35 人开始时间: 2008年4月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. severe cardiac effusion 2. severe supra vena cava syndrome 3. severe complication (angina pectoris, myocardial infarction, heart failure, diabetes, hypertension, infection, interstitial pneumonia) 4. active other cancer 5. pregnancy women 6. need radiotherapy for brain metastasis 7. limited stage small cell lung cancer
研究者
相似试验
已完成
2 期
Phase II trial of amrubicin and cisplatin chemotherapy for invasive thymomathymomaJPRN-UMIN000003933West Japan Oncology Group40
已完成
2 期
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung CancerExtensive-Stage Small Cell Lung CancerNCT01076504SCRI Development Innovations, LLC81
已完成
2 期
A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung canceron-Small Cell Lung Cancer,Squamous cell lung cancerJPRN-UMIN000007102ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine25
已完成
2 期
Randomized phase II trial comparing amrubicine/irinotecan with cisplatin/irinotecan in patients with extensive-stage small-cell lung cancer: (JMTO LC 08-01)extensive-disease small-cell lung cancerJPRN-UMIN000001246The Japan-multinational Trial Organization100
已完成
1 期
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35